Literature DB >> 15572486

Seven-year follow-up of the tension-free vaginal tape procedure for treatment of urinary incontinence.

Carl Gustaf Nilsson1, Christian Falconer, Masoumeh Rezapour.   

Abstract

OBJECTIVE: To evaluate the long-term cure rates and late complication rates after treatment of female urinary stress incontinence with the minimally invasive tension-free vaginal tape operation.
METHODS: Prospective observational, 3-center cohort study originally of 90 women requiring surgical treatment for primary urinary stress incontinence. Assessment variables included a 24-hour pad weighing test, a stress test, visual analog scale for assessing the degree of bother, and a questionnaire assessing the subjective perception of the women on their continence status.
RESULTS: The follow-up time was a mean of 91 months (range 78-100 months). Both objective and subjective cure rates were 81.3% for the 80 women available for follow-up. Asymptomatic pelvic organ prolapse was found in 7.8%, de novo urge symptoms in 6.3%, and recurrent urinary tract infection in 7.5% of the women. No other long-term adverse effects of the procedure were detected.
CONCLUSION: The tension-free vaginal tape procedure for treatment of female urinary stress incontinence is effective over a period of 7 years.

Entities:  

Mesh:

Year:  2004        PMID: 15572486     DOI: 10.1097/01.AOG.0000146639.62563.e5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  76 in total

1.  Long-term subjective results of tension-free vaginal tape operation for female urinary stress incontinence.

Authors:  Karin Glavind; Emilie Glavind; Morten Fenger-Grøn
Journal:  Int Urogynecol J       Date:  2011-11-18       Impact factor: 2.894

2.  Complications associated with transobturator sling procedures.

Authors:  Sarah Hamilton Boyles; Renee Edwards; William Gregory; Amanda Clark
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-28

3.  Funneling before and after anti-incontinence surgery--a prognostic indicator? Part 2: tension-free vaginal tape.

Authors:  Lena Harms; Günter Emons; Werner Bader; Rainer Lange; Reinhard Hilgers; Volker Viereck
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-18

4.  Cecal perforation complicating placement of a transvaginal tension-free vaginal tape.

Authors:  Daniel D Gruber; Donald S Wiersma; James S Dunn; Kent A Meldrum; Thomas C Krivak
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-06

5.  Anatomical variability in the trajectory of the inside-out transobturator vaginal tape technique (TVT-O).

Authors:  Piet Hinoul; Linda Vanormelingen; Jan-Paul Roovers; Eric de Jonge; Stéfan Smajda
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-24

6.  Randomized trial of a comparison of the efficacy of TVT-O and single-incision tape TVT SECUR systems in the treatment of stress urinary incontinent women--2-year follow-up.

Authors:  Jaromir Masata; Kamil Svabik; Karel Zvara; Petra Drahoradova; Rachid El Haddad; Petr Hubka; Alois Martan
Journal:  Int Urogynecol J       Date:  2012-10       Impact factor: 2.894

7.  Prediction of successful voiding immediately after outpatient mid-urethral sling.

Authors:  Kenneth I Barron; Judith A Savageau; Stephen B Young; Lisa C Labin; Abraham N Morse
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-01

8.  Does concomitant vaginal prolapse repair affect the outcomes of the transobturator tape procedure in the long term?

Authors:  Tarik Yonguc; Bulent Gunlusoy; Burak Arslan; Ibrahim Halil Bozkurt; Zafer Kozacioglu; Tansu Degirmenci; Omer Koras
Journal:  Int Urogynecol J       Date:  2014-04-26       Impact factor: 2.894

9.  The Trial of Mid-Urethral Slings (TOMUS): Design and Methodology.

Authors: 
Journal:  J Appl Res       Date:  2008

10.  TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial.

Authors:  Ladislav Krofta; Jaroslav Feyereisl; Michal Otcenásek; Petr Velebil; Eva Kasíková; Michal Krcmár
Journal:  Int Urogynecol J       Date:  2009-11-12       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.